UniProt ID | HDAC9_HUMAN | |
---|---|---|
UniProt AC | Q9UKV0 | |
Protein Name | Histone deacetylase 9 | |
Gene Name | HDAC9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1011 | |
Subcellular Localization | Nucleus. | |
Protein Description | Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Represses MEF2-dependent transcription.; Isoform 3 lacks active site residues and therefore is catalytically inactive. Represses MEF2-dependent transcription by recruiting HDAC1 and/or HDAC3. Seems to inhibit skeletal myogenesis and to be involved in heart development. Protects neurons from apoptosis, both by inhibiting JUN phosphorylation by MAPK10 and by repressing JUN transcription via HDAC1 recruitment to JUN promoter.. | |
Protein Sequence | MHSMISSVDVKSEVPVGLEPISPLDLRTDLRMMMPVVDPVVREKQLQQELLLIQQQQQIQKQLLIAEFQKQHENLTRQHQAQLQEHIKELLAIKQQQELLEKEQKLEQQRQEQEVERHRREQQLPPLRGKDRGRERAVASTEVKQKLQEFLLSKSATKDTPTNGKNHSVSRHPKLWYTAAHHTSLDQSSPPLSGTSPSYKYTLPGAQDAKDDFPLRKTASEPNLKVRSRLKQKVAERRSSPLLRRKDGNVVTSFKKRMFEVTESSVSSSSPGSGPSSPNNGPTGSVTENETSVLPPTPHAEQMVSQQRILIHEDSMNLLSLYTSPSLPNITLGLPAVPSQLNASNSLKEKQKCETQTLRQGVPLPGQYGGSIPASSSHPHVTLEGKPPNSSHQALLQHLLLKEQMRQQKLLVAGGVPLHPQSPLATKERISPGIRGTHKLPRHRPLNRTQSAPLPQSTLAQLVIQQQHQQFLEKQKQYQQQIHMNKLLSKSIEQLKQPGSHLEEAEEELQGDQAMQEDRAPSSGNSTRSDSSACVDDTLGQVGAVKVKEEPVDSDEDAQIQEMESGEQAAFMQQPFLEPTHTRALSVRQAPLAAVGMDGLEKHRLVSRTHSSPAASVLPHPAMDRPLQPGSATGIAYDPLMLKHQCVCGNSTTHPEHAGRIQSIWSRLQETGLLNKCERIQGRKASLEEIQLVHSEHHSLLYGTNPLDGQKLDPRILLGDDSQKFFSSLPCGGLGVDSDTIWNELHSSGAARMAVGCVIELASKVASGELKNGFAVVRPPGHHAEESTAMGFCFFNSVAITAKYLRDQLNISKILIVDLDVHHGNGTQQAFYADPSILYISLHRYDEGNFFPGSGAPNEVGTGLGEGYNINIAWTGGLDPPMGDVEYLEAFRTIVKPVAKEFDPDMVLVSAGFDALEGHTPPLGGYKVTAKCFGHLTKQLMTLADGRVVLALEGGHDLTAICDASEACVNALLGNELEPLAEDILHQSPNMNAVISLQKIIEIQSMSLKFS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MHSMISSVDV -----CCCCCCCCEE | 29.66 | 24043423 | |
6 | Phosphorylation | --MHSMISSVDVKSE --CCCCCCCCEECCC | 18.70 | 24043423 | |
7 | Phosphorylation | -MHSMISSVDVKSEV -CCCCCCCCEECCCC | 16.06 | 24043423 | |
12 | Phosphorylation | ISSVDVKSEVPVGLE CCCCEECCCCCCCCC | 43.61 | 24043423 | |
22 | Phosphorylation | PVGLEPISPLDLRTD CCCCCCCCCCCHHHC | 30.08 | 28674151 | |
44 | Ubiquitination | VDPVVREKQLQQELL CCHHHCHHHHHHHHH | 45.82 | - | |
140 | Phosphorylation | GRERAVASTEVKQKL CCHHHHCCHHHHHHH | 20.64 | 27794612 | |
141 | Phosphorylation | RERAVASTEVKQKLQ CHHHHCCHHHHHHHH | 34.75 | 27794612 | |
177 | Phosphorylation | SRHPKLWYTAAHHTS CCCCCCEEEECCCCC | 9.27 | 27080861 | |
178 | Phosphorylation | RHPKLWYTAAHHTSL CCCCCEEEECCCCCC | 13.04 | 23898821 | |
183 | Phosphorylation | WYTAAHHTSLDQSSP EEEECCCCCCCCCCC | 22.55 | 27080861 | |
184 | Phosphorylation | YTAAHHTSLDQSSPP EEECCCCCCCCCCCC | 26.12 | 23898821 | |
188 | Phosphorylation | HHTSLDQSSPPLSGT CCCCCCCCCCCCCCC | 44.47 | 23898821 | |
189 | Phosphorylation | HTSLDQSSPPLSGTS CCCCCCCCCCCCCCC | 25.55 | 27080861 | |
191 (in isoform 11) | Phosphorylation | - | 40.90 | - | |
217 | Ubiquitination | KDDFPLRKTASEPNL CCCCCCCCCCCCCCH | 57.01 | - | |
218 | Phosphorylation | DDFPLRKTASEPNLK CCCCCCCCCCCCCHH | 29.05 | 30183078 | |
220 | Phosphorylation | FPLRKTASEPNLKVR CCCCCCCCCCCHHHH | 59.84 | 25159151 | |
224 (in isoform 9) | Phosphorylation | - | 8.74 | - | |
227 (in isoform 6) | Phosphorylation | - | 17.93 | - | |
239 | Phosphorylation | QKVAERRSSPLLRRK HHHHHHCCCCCCCCC | 42.39 | 25159151 | |
240 | Phosphorylation | KVAERRSSPLLRRKD HHHHHCCCCCCCCCC | 20.11 | 26846344 | |
253 | Phosphorylation | KDGNVVTSFKKRMFE CCCCEEECEEHHHEE | 24.37 | 20188095 | |
266 (in isoform 8) | Phosphorylation | - | 10.03 | - | |
409 | Ubiquitination | KEQMRQQKLLVAGGV HHHHHHCCCHHCCCC | 35.14 | - | |
422 | Phosphorylation | GVPLHPQSPLATKER CCCCCCCCCCCCCCC | 26.74 | 28450419 | |
426 | Phosphorylation | HPQSPLATKERISPG CCCCCCCCCCCCCCC | 40.91 | 28450419 | |
449 | Phosphorylation | RHRPLNRTQSAPLPQ CCCCCCCCCCCCCCH | 26.29 | 30108239 | |
451 | Phosphorylation | RPLNRTQSAPLPQST CCCCCCCCCCCCHHH | 31.10 | 22617229 | |
457 | Phosphorylation | QSAPLPQSTLAQLVI CCCCCCHHHHHHHHH | 24.37 | 28450419 | |
458 | Phosphorylation | SAPLPQSTLAQLVIQ CCCCCHHHHHHHHHH | 22.36 | 27080861 | |
477 (in isoform 11) | Phosphorylation | - | 38.48 | 25954137 | |
488 (in isoform 11) | Phosphorylation | - | 6.91 | 29523821 | |
491 | Phosphorylation | MNKLLSKSIEQLKQP HHHHHHHHHHHHHCC | 28.16 | 28787133 | |
510 (in isoform 9) | Phosphorylation | - | 57.61 | 25954137 | |
521 (in isoform 9) | Phosphorylation | - | 29.89 | 29523821 | |
526 (in isoform 10) | Phosphorylation | - | 28.82 | 25954137 | |
537 (in isoform 10) | Phosphorylation | - | 24.35 | 29523821 | |
552 (in isoform 8) | Phosphorylation | - | 14.40 | 25954137 | |
554 | Phosphorylation | VKEEPVDSDEDAQIQ EEECCCCCCHHHHHH | 43.03 | 26434776 | |
554 (in isoform 3) | Phosphorylation | - | 43.03 | 25954137 | |
563 (in isoform 8) | Phosphorylation | - | 2.59 | 29523821 | |
565 (in isoform 3) | Phosphorylation | - | 46.44 | 29523821 | |
607 | Phosphorylation | LEKHRLVSRTHSSPA HHHHCCCCCCCCCCC | 35.73 | 23286773 | |
609 | Phosphorylation | KHRLVSRTHSSPAAS HHCCCCCCCCCCCHH | 20.71 | 26434776 | |
611 | Phosphorylation | RLVSRTHSSPAASVL CCCCCCCCCCCHHCC | 37.09 | 26434776 | |
612 | Phosphorylation | LVSRTHSSPAASVLP CCCCCCCCCCHHCCC | 15.79 | 26434776 | |
616 | Phosphorylation | THSSPAASVLPHPAM CCCCCCHHCCCCCCC | 26.71 | 26434776 | |
631 | Phosphorylation | DRPLQPGSATGIAYD CCCCCCCCCCCCCCC | 29.37 | 23286773 | |
633 | Phosphorylation | PLQPGSATGIAYDPL CCCCCCCCCCCCCCC | 30.71 | 23286773 | |
637 | Phosphorylation | GSATGIAYDPLMLKH CCCCCCCCCCCCCCE | 19.04 | 23286773 | |
663 | Phosphorylation | EHAGRIQSIWSRLQE HHHHHHHHHHHHHHH | 24.53 | 28857561 | |
767 | Phosphorylation | ELASKVASGELKNGF HHHHHHHCCCCCCCE | 35.47 | 29396449 | |
966 (in isoform 6) | Phosphorylation | - | 48.05 | 17081983 | |
996 | Phosphorylation | PNMNAVISLQKIIEI CCHHHEEEHHHHHHH | 20.39 | 24719451 | |
1007 (in isoform 5) | Phosphorylation | - | 33.38 | 17081983 | |
1010 (in isoform 7) | Phosphorylation | - | 14.72 | 17081983 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HDAC9_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00313 | Valproic Acid |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND MASSSPECTROMETRY. |